Vitamin D epimer: a significant bioregulator or an inactive compound?

Osteoporosis International

Volumn 26, Issue 9, 2015, Pages 2345-2346

  Karras, S ^a   Petroczi, A ^b   Anagnostis, P ^a   Naughton, D P ^b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b KINGSTON UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; 3 EPI 25 HYDROXYVITAMIN D3; CALCIFEDIOL; COLECALCIFEROL; UNCLASSIFIED DRUG; VITAMIN D;

CHRONIC DISEASE; DISEASE ACTIVITY; EPIMER; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LETTER; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; BLOOD; FEMALE; MALE;

CALCIFEDIOL; FEMALE; HUMANS; MALE;

EID: 84938970841     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-015-3198-7     Document Type: Letter

References (3)

1. Chailurkit L, Aekplakorn W, Ongphiphadhanakul B (2015) Serum C3 epimer of 25-hydroxyvitamin D and its determinants in adults: a national health examination survey in Thais. Osteoporos Int. Apr 14. [Epub ahead of print]
2. Shah I, Petroczi A, Naughton DP (2014) Exploring the roles of vitamin D in Type 1 diabetes, rheumatoid arthritis, and Alzheimer Disease: new insights from accurate analysis of 10 forms. J Clin Endocrinol Metab 99:808–816
3. Karras SN, Shah I, Petroczi A, Goulis DG, Bili H, Papadopoulou F, Harizopoulou V, Tarlatzis BC, Naughton DP (2013) An observational study reveals that neonatal vitamin D is primarily determined by maternal contributions: implications of a new assay on the roles of vitamin D forms. Nutr J 12:77